arrow
S

Sophie Allen

The Institute of Cancer Research
H指数:10
被引数:383

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Routine germline genetic testing in 3552 unselected NHS breast cancer patients: evidence informing testing criteria and implementation of a ‘BRCA-DIRECT’ mainstreaming pathway

对3552例未经选择的NHS乳腺癌患者进行常规生殖系遗传检测:为检测标准提供证据并实施“BRCA-DIRECT”常规化路径

2026-07-090
OA
Availability of benign missense variant “truthsets” for validation of functional assays: Current status and a systematic approach

良性错义变异“真实集合”在功能测定验证中的可用性:现状与系统方法

2025-09-080
PRE
Quantifying evidence for phenotypic specificity (PP4) for syndromic phenotypes: Large-scale integration of rare germline FH variants from diagnostic laboratory testing for HLRCC (Hereditary Leiomyomatosis and Renal Cell Cancer) and renal cancer

量化综合征表型(PP4)特异性证据:大规模整合来自HLRCC(遗传性平滑肌瘤病和肾细胞癌)及肾癌诊断实验室检测的罕见生殖系FH变异

2025-09-040
OAAI
Long-term health outcomes of bilateral salpingo-oophorectomy in BRCA1 and BRCA2 pathogenic variant carriers with personal history of breast cancer: a retrospective cohort study using linked electronic health records

BRCA1和BRCA2致病性变异携带者中,有乳腺癌病史者行双侧输卵管卵巢切除术的长期健康结局:一项基于关联电子健康记录的回顾性队列研究

2025-05-080
OA
Lynch syndrome diagnostic testing pathways in endometrial cancers: a nationwide English registry-based study

子宫内膜癌的Lynch综合征诊断测试途径: 一项基于全国英语注册的研究

2024-10-210
OAAI
BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial

BRCA-英国乳腺肿瘤学环境中诊断性种系基因检测的直接数字途径: 一项随机,非劣效性试验

2024-10-011
OA
Second primary cancer risks following breast cancer in BRCA1/2 pathogenic variant carriers
2024-03-220
PRE
Recommendations for laboratory workflow that better support centralised amalgamation of genomic variant data: findings from CanVIG-UK national molecular laboratory survey
2023-12-221
OAAI
Germline mismatch repair (MMR) gene analyses from English NHS regional molecular genomics laboratories 1996-2020: development of a national resource of patient-level genomics laboratory records

来自英国NHS区域分子基因组学实验室的种系错配修复 (MMR) 基因分析1996-2020: 患者水平基因组学实验室记录的国家资源的开发

2022-12-267
OAAI
UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2

英国关于癌症易感基因种系致病变异女性癌症风险临床管理的共识建议: RAD51C,RAD51D,BRIP1和PALB2

2022-11-2125
OAAI
Reclassification of clinically-detected sequence variants: Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK)
2022-09-0117
OAAI
A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot

英国NHS癌症患者基因检测的数字途径: brca-direct随机研究内部试点

2022-07-2222
OAAI
Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants
2022-03-016
OAAI